Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddys launches anti-phlegm OTC drug in US market
OTC Guaifenesin and Pseudoephedrine HCl are used to help loosen phlegm (mucus) and thin bronchial secretions
Govt to reduce granting environmental clearances to 70-80 days: Prakash Javadekar
The minister spoke about the acute need to ruthless implementation of environmental laws at ‘Annual Conference on Chemical and…
Glenmark Pharmaceuticals receives ANDA approval for Ranolazine
Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg are a generic version of Ranexa Extended-Release Tablets, 500 mg and…
Jiva Ayurveda to offer free consultation across India during the Jiva Health Week
More than 10 thousand patients are expected to benefit during the health week. The company is also is also giving free…
Union Health Ministry’s proposal to classify ENDS devices as ‘drugs’ sent to…
Banning alternative smoking devices like e-cigarettes, heat-not-burn devices, vape and e-nicotine flavoured hookah, etc is one of…
USFDA issues 12 observations for three Biocon units in Malaysia
The inspection across these three units concluded with 12 observations issued on the Form 483
FDA pulls up Aurobindo Pharma for ‘repeated’ failures in CGMP
The FDA recently issued a letter warning the drug- makers unit X1 in Srikakulam district of Andhra Pradesh for deviations from…
Dr Reddy’s Laboratories plans to launch value-added drugs in US
Dr Reddy's Laboratories has said the company plans to launch several value-added products this fiscal to offset the persisting…
Budget reactions 2019
Union Budget 2019 evokes mixed reviews from the pharmaceutical industry
Satish Reddy, Chairman, Dr Reddy’s Laboratories
The…